https://lodoco.com
A new approach for heart-attack prevention. LODOCO (0.5mg colchicine tablets) the first ever medicine to treat cardiovascular inflammation, approved by the Food and Drug Administration in June, is now available to patients and prescribers nationwide.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesACC.24 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies, Interventional and Structural Cardiology, Ischemic Heart Disease, Prevention and Health PromotionFirst time Exhibitor?
Yes